GlassScriptPhysician profile
Andrew Kim
NPI 1417100918
$10,996.12
in general payments reported to CMS, 2019-2025
57 companies · $978 in 2025
The $978 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,448 · 2020: $2,103 · 2021: $1,606 · 2022: $1,661 · 2023: $944 · 2024: $1,256 · 2025: $978.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,178.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,593.99 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Intracept |
| Scilex Pharmaceuticals INC. | $706.18 | 2019-2024 | Ztlido |
| Medtronic, INC. | $554.55 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Vanta Adaptivestim |
| Biotronik Nro, INC. | $474.96 | 2023-2025 | Prospera, Biotronik |
| Vertos Medical, INC. | $451.74 | 2020-2024 | Mild Device Kit |
| Medtronic USA, INC. | $436.79 | 2019-2020 | |
| Flowonix Medical Incorporated | $426.03 | 2019-2020 | |
| Abbvie INC. | $362.09 | 2021-2025 | |
| Foundation Fusion Solutions, LLC | $344.51 | 2020 | |
| Saluda Medical Americas, INC. | $322.97 | 2023-2024 | Evoke, Evoke Scs |
| Vertiflex, INC. | $322.43 | 2019 | |
| Forte Bio-Pharma LLC | $257.01 | 2021-2024 | Prolate, Nalocet |
| Abbott Laboratories | $239.03 | 2021-2025 | Freestyle Libre 3 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $219.76 | 2019-2022 | |
| Zyla Life Sciences, INC. | $187.66 | 2019-2020 |
Show all 56 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.